Thromboprophylaxis in COVID-19: Early initiation might be as important as optimal dosing

Thromb Res. 2021 Aug:204:134-135. doi: 10.1016/j.thromres.2021.06.004. Epub 2021 Jun 16.

Authors

Anastasios Kollias¹, Garyphallia Poulakou², Evangelos Dimakakos², Konstantinos G Kyriakoulis², Konstantinos Syrigos²

Affiliations

¹ National and Kapodistrian University of Athens, School of Medicine, Third Department of Medicine, Sotiria Hospital, Athens, Greece. Electronic address: taskollias@gmail.com.
² National and Kapodistrian University of Athens, School of Medicine, Third Department of Medicine, Sotiria Hospital, Athens, Greece.

No abstract available

Keywords: Anticoagulation; COVID-19; Dosage; Thromboprophylaxis; Timing.

Publication types

Letter
Comment

MeSH terms

Anticoagulants / therapeutic use
COVID-19*
Humans
SARS-CoV-2
Venous Thromboembolism*

Substances

Anticoagulants